The beneficial effect on sugar metabolism of a food supplement based on plant extracts, zinc and chromium
- Conditions
- Impaired fasting plasma glucose (fasting plasma glucose between 90 and 120 mg/dL)Nutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN15697400
- Lead Sponsor
- ational Inter-university Consortium of Research in Innovative Pharmaceutical Technologies - Tefarco Innova
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 81
1. Aged 18-75 years old of both sexes
2. Able to understand and sign the informed consent
3. 98 mg/dL < impaired fasting glycemia < 125 mg/d
1. Aged < 18 and > 75 years old
2. A medical history or condition that could affect the subject's safety or negatively impact the validity of the study results
3. Pregnant or breastfeeding women
4. With a history of allergy to ingredients contained in the study treatments (dietary supplement and placebo)
5. Exposed to a high risk of cardiovascular events based on 8 risk factors (sex, age, diabetes, smoking habits, systolic blood pressure, total cholesterolemia, hdl-cholesterolemia and antihypertensive treatment)
6. Following drug therapy for diabetes even at low dosages
7. Taking supplements to control cholesterol, blood sugar and metabolic syndrome, in the two weeks prior to recruitment
8. Women who suspect pregnant or planning pregnancy
9. Blood donors in the three months prior to recruitment
10. Non-self-sufficient individuals
11. Who does not show a propensity to collaborate
12. Who have difficulty getting to the reference facility within the scheduled time
13. Who are not considered suitable by the investigators due to the presence of other pathologies considered incompatible with enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method